rhTPO
IIT2022037
Approved small_molecule completed
Quick answer
rhTPO for Previously Treated Primary Immune Thrombocytopenia is a Approved program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Previously Treated Primary Immune Thrombocytopenia
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed